NLARx Newsletter Header
NLARx News
June 17, 2009
In This Issue
NLARx News
In the States
Outrage of the Week
Prices & Access
Patents & Generics
Conflicts of Interest
Advertising & Marketing
Pharma Watch
PBM Watch
Comparative Effectiveness
Medicare
Safety & Clinical Trials
Quick Links
Join Our Mailing List
Save the Date!
NLARx will host two panels at the July conference of the National Conference of State Legislators: "Do Trade Policies Threaten Access to Affordable Medicines in the States?" (July 21) and "Data, Drugs and Disclosure: States Lead the Way on Pharmaceutical Policy" (July 24) More
NLARx News
NLARx on Progressive Delegation, Meets With Members of Congress and HHS Secretary Kathleen Sibelius to Push Public Health Plan More
Vermont Governor Signs Sweeping Gift Ban and Disclosure Law More
CVS Caremark Merger Attacked by Pharmacists and NLARx Members More
In the States
MAINE: Moratorium on Pharmaceutical Crops Signed Into Law More
New Predatory Marketing Ban Law Protects Minors More
VERMONT: New Law on Marketing Prescribed Products Sets Higher Bar More
NEW HAMPSHIRE: Legislature Passes Protections On Use of Individual Health Information for Marketing and Fundraising More
NEW JERSEY: Officials OK Measure on Generic Prescriptions More
PENNSYLVANIA: State Sues Merck and Schering Over Vytorin More
WEST VIRGINIA: State Seeks $2 Billion from Lilly More
DELAWARE: Drugstores Group Sues State Over Medicaid Cutbacks More
MINNESOTA: Pharmaceutical Companies Spending Less on Doctors More
NORTH CAROLINA: Clout Keeps Generics Out, but Budget Shortfall Could Spur Change More
Outrage of the Week
Lilly 'Ghostwrote' Zyprexa Studies, Documents Show More
Prices and Access to Healthcare
MedPAC: Are New Drugs Worth Higher Prices? More
Drugstores Group Sues Delaware Over Medicaid Cutbacks More
Bayer Pharma Chief Laments Pricing Pressures More
GSK Price-Cutting Emboldens Russian Government More
Glaxo at Loggerheads With Russia Over HIV Drugs More
U.S. Senate Vote Deferred on Drug Importation Measure More
Medical Bankruptcies Soar More
Trends In Underinsurance And The Affordability Of Employer Coverage, 2004-2007 More
Merck, Lilly Reject Public Health Plan More
Settlements May Give Some Relief on Drug Prices More
Congress Grills Generics Firms on Pay-for-Delay More
Patents and Generics
As Patent Cliff Nears, More Lawsuits Filed More
FTC Testifies on "Competition Issues and Follow-on Biologic Drugs" More
Bill to End Generic Drug Delays Clears House Subcommittee More
Pfizer Revving up for Generics Growth More
GPhA Statement on FTC Report on "Follow-on Biologic Drug Competition" More
Congress Grills Generics Firms on Pay-for-Delay More
J&J Could Try its Hand Selling Branded Generics Abroad More
Row Over Generic Drugs Intensifies After Seizure in Germany More
Conflicts of Interest
AMSA Reports One Fifth of Med Schools Reduced Ties with Drug Firms More
Spurred by Nemeroff Debacle, Emory Reforms Ethics More
Advertising and Marketing
House Considering Denying Tax Deductions for Pharmaceutical Advertising More
Federal Bill Aims To Disclose Doctor-Drugmaker Payments More
Vermont Bill Would Disclose Drugmaker-Doctor Payments More
Medical Industry Showers DOD with Free Travel More
Key Findings of Study on Medical Industry Funding of Pentagon Travel More
Social Media Still Uncharted for Pharma More
Drug Firms Jockey for Space Online More
Missing FDA Letters Found. More Questions. More
Will Supremes Hear IMS Data-Mining Case? More
Pharmacists Traveling on Industry's Dime More
Internet Advertising Has Stopped Dead in Its Tracks! More
Drug-Maker Pens Are Endangered Species at Cancer Confab More
Microsoft Buys Genetic Data Software from Merck More
Pharma Watch
Germans Accuse Pfizer of Sitting on Data More
PhRMA Statement on Health Care Reform More
Missing FDA Letters Found. More Questions More
Merck, Lilly Reject Public Health Plan More
GSK Teams with Chinese Firm to Tap World's Largest Flu Vaccine Market More
Pharma Lobbying: A Bitter Pill to Swallow More
Lilly Balks at AG's $2B Zyprexa Suit More
Benefits Fund Sues Merck, Schering Over Vytorin More
Judge's Sentence for Former Bristol-Myers Exec: Write a Book More
After Scandal, Elsevier Plans Reprint Rules More
Judge: CafePharma Posts Stay in Schering Case More
Monsanto, BASF Add Bacteria Gene to Corn for Drought More
PBM Watch
CVS Unit 'Played Both Sides' on Top Drug More
Zyprexa Suit Highlights CVS Links to Lilly More
CIGNA Weighs Sale of Drug Benefits Unit More
Cigna's Drug Unit Could Fetch $1.3 Billion More
The Death of the Corner Pharmacy More
CVS Caremark To Pay Fine To End Suit In Sale Of Old Products More
Comparative Effectiveness Research
Baucus: Don't Like Comparative Effectiveness? Meet 'Fred' More
Diabetes Study Questions Expensive Treatments More
Discounted Erbitux gets NICE Nod More
Medicare and Medicaid
New Analysis Reveals Rising Costs for Medicare Part D Enrollees Over Time  More
TennCare Reaches Largest Pharma Overbilling Settlement More
Medicare Tapped For Savings to Cover Reform Costs, Again More
PhRMA Launches Campaign to Raise Awareness Of Success of Medicare Prescription Drug Benefit More
Seniors Seek Help With Medicare's 'Doughnut Hole' More
Safety and Clinical Trials
Study Shows Possible Link Between Deaths and ADHD Drugs More
FDA: Zicam Nasal Spray Can Cause Loss of Smell More
Zicam Cold Remedy Gets FDA Warning; Matrixx Dives More
Attention Drugs May Be Linked to Sudden Death in Children More
FDA Wants Precaution on Singulair, Sister Meds More
Drugmakers Draw U.S. High Court Query on Vaccine Suit Shield  More
FDA Wants to Keep Fewer Secrets More
Germans Accuse Pfizer of Sitting on Data More
Fraud and Abuse?
Ex-Bristol-Myers Executive Sentenced to Write Book More
Bone Growth Fraud? More
Sanofi to Pay $95.5M to Settle Medicaid Pricing Dispute More